Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank43
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-51.97M
↑ 20% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-65.10M
Historical baseline
PeriodValueYoY Change
TTM$-51.97M+15.2%
2024$-61.27M-13.1%
2023$-54.15M-12.5%
2022$-48.13M-15.9%
2021$-41.51M-178.3%
2020$-14.92M-40.9%
2019$-10.59M+95.6%
2018$-238.30M-